Emmaus Life Sciences, Inc. financial data

Symbol
EMMA on OTC
Location
Torrance, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 8.72 % -41.5%
Quick Ratio 2.2 % -14.4%
Debt-to-equity -139 % +10.6%
Return On Assets -32.3 % -173%
Operating Margin -10.2 % -11667%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63.9M shares 0%
Common Stock, Shares, Outstanding 63.9M shares 0%
Entity Public Float 4.08M USD -54%
Common Stock, Value, Issued 64K USD 0%
Weighted Average Number of Shares Outstanding, Basic 63.9M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 63.9M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 11.9M USD -41.8%
Cost of Revenue 931K USD -14%
Research and Development Expense 419K USD -38.9%
Selling and Marketing Expense 3.09M USD -56.9%
General and Administrative Expense 8.66M USD -24.4%
Operating Income (Loss) -1.21M USD -6833%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.29M USD -103%
Income Tax Expense (Benefit) -1K USD +98.9%
Net Income (Loss) Attributable to Parent -7.29M USD -108%
Earnings Per Share, Basic 0 USD/shares -200%
Earnings Per Share, Diluted 0 USD/shares -300%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 293K USD -76.7%
Accounts Receivable, after Allowance for Credit Loss, Current 2.62M USD -47%
Inventory, Net 1.21M USD -24.7%
Other Assets, Current 315K USD -61.4%
Assets, Current 4.79M USD -48%
Property, Plant and Equipment, Net 128K USD +161%
Operating Lease, Right-of-Use Asset 799K USD -53.5%
Other Assets, Noncurrent 167K USD -46.5%
Assets 20.8M USD -24.1%
Accounts Payable, Current 5.36M USD -17.4%
Accrued Liabilities, Current 9.56M USD +21.6%
Liabilities, Current 64.2M USD +0.06%
Operating Lease, Liability, Noncurrent 1.5M USD +39.2%
Other Liabilities, Noncurrent 12.3M USD -9.97%
Liabilities 80.2M USD -1.09%
Accumulated Other Comprehensive Income (Loss), Net of Tax -481K USD +76.1%
Retained Earnings (Accumulated Deficit) -268M USD -2.8%
Stockholders' Equity Attributable to Parent -59.5M USD -10.6%
Liabilities and Equity 20.8M USD -24.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 279K USD +99.3%
Net Cash Provided by (Used in) Financing Activities -345K USD +63.9%
Net Cash Provided by (Used in) Investing Activities -4K USD +99.6%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 63.9M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -56K USD +93.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 415K USD -52.5%
Deferred Tax Assets, Valuation Allowance 38.8M USD -9.46%
Deferred Tax Assets, Gross 39.3M USD -9.37%
Operating Lease, Liability 1.8M USD -47.1%
Depreciation 29K USD +20.8%
Payments to Acquire Property, Plant, and Equipment 4K USD -33.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5.75M USD -43.5%
Lessee, Operating Lease, Liability, to be Paid 2.26M USD -38.1%
Property, Plant and Equipment, Gross 509K USD -3.05%
Operating Lease, Liability, Current 348K USD -85.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 506K USD -40.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 510K USD -54.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure -15.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 413K USD +70%
Lessee, Operating Lease, Liability, to be Paid, Year Three 513K USD
Deferred Tax Assets, Operating Loss Carryforwards 19.5M USD +10.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) -23K USD +81.5%
Current Federal Tax Expense (Benefit) 0 USD
Depreciation, Depletion and Amortization 5K USD -16.7%
Deferred Tax Assets, Net of Valuation Allowance 426K USD -0.23%
Interest Expense 6.14M USD -3.91%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%